Specify a stock or a cryptocurrency in the search bar to get a summary
MicroTech Med (Hangzhou) Co
2235MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and sale of medical devices for diabetes monitoring, treatment, and management in the People's Republic of China and internationally. The company offers Equil patch insulin pump systems; AiDEX and LinX continuous glucose monitoring systems; POCT analyzer systems; closed-loop artificial pancreas systems; blood glucose monitoring systems; Exactive Pro blood glucose, blood ketone, and uric acid monitoring system; and diabetes digital management software. It is also involved in scientific research and technical services; business services; wholesale and retail; manufacturing; and commercials. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China. Address: No. 108 Liuze Street, Hangzhou, China
Analytics
WallStreet Target Price
44.64 HKDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 2235
Dividend Analytics 2235
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2235
Stock Valuation 2235
Financials 2235
Results | 2019 | Dynamics |